Search

Your search keyword '"Iteld B"' showing total 35 results

Search Constraints

Start Over You searched for: Author "Iteld B" Remove constraint Author: "Iteld B"
35 results on '"Iteld B"'

Search Results

1. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

2. Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice:: GLORIA-AF Registry

3. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

4. Dapagliflozin and cardiovascular outcomes in type 2 diabetes

5. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

6. Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry

7. Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)

8. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

9. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

10. Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure

11. The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

12. Evolocumab and clinical outcomes in patients with cardiovascular disease

13. Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

14. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

15. The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

18. Alogliptin after acute coronary syndrome in patients with type 2 diabetes

19. Antiinflammatory therapy with canakinumab for atherosclerotic disease

21. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

22. Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation. the GLORIA-AF registry

23. Effects of omapatrilat on hemodynamics and safety in patients with heart failure.

24. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

25. Implanted Monitor Alerting to Reduce Treatment Delay in Patients With Acute Coronary Syndrome Events.

26. Implantable Cardiac Alert System for Early Recognition of ST-Segment Elevation Myocardial Infarction.

27. Duration of effects of isradipine during twice daily therapy in angina pectoris.

28. Acute nontraumatic cardiac tamponade.

29. The prolonged effect of pentaerythritol tetranitrate on exercise capacity in stable effort angina pectoris.

30. The cardiomyopathy of hypoparathyroidism. Another reversible form of heart muscle disease.

31. Short-term effects of intravenous clonidine in congestive heart failure.

32. Coronary artery spasm: a mechanism of chest pain in selected patients with the mitral valve prolapse syndrome.

33. Racial differences in platelet survival time in patients with symptomatic coronary atherosclerosis.

35. Limitations of ergonovine testing in patients with variant angina.

Catalog

Books, media, physical & digital resources